Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

bavunalimab (XmAb22841)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Xencor

Drug class:

CTLA4 inhibitor, LAG-3 inhibitor

Related drugs:

ipilimumab (223)

tremelimumab-actl (60)

cadonilimab (10)

iparomlimab/tuvonralimab (3)

ipilimumab biosimilar (CS1002) (2)

CTLA4 inhibitor (0)

IBI310 (ipilimumab biosimilar) (0)

prolgolimab/nurulimab (0)

PF-06753512 (0)

nivolumab/relatlimab-rmbw (4)

›